The complex nature of the interactions between the microbe, tumor, and immune system requires multidisciplinary collaboration between microbiologists, cancer researchers, and immunologists with the goal of developing innovative approaches to improve our understanding of this system and utilize it for cancer therapy. This initiative seeks to support studies of tumor-microbe interactions needed to develop new cancer imaging and therapy strategies that address unmet clinical needs. The multi-disciplinary research teams are expected to conduct cutting-edge research aimed at advancing pre-clinical development of novel bacteria-based anticancer therapeutic or diagnostic agents. The goal is to conduct research that could have a major impact on cancer therapy and related research
Multi-disciplinary research teams are expected to conduct cutting-edge research within the scope of the funding opportunity announcement (FOA) aimed at advancing pre-clinical development of novel microbial-based anticancer therapeutic agents, cancer imaging, and diagnostics technologies, or to study the complex biology involved in the interplay of microbe-tumor-immune system interactions. Applicants applying to this FOA are expected to address both the microbial and the tumor aspects of microbial cancer therapy, the goal is to conduct research that could have a major impact on cancer therapy and related research.
Funder: National Institute of Health
URL: https://grants.nih.gov/grants/guide/pa-files/PAR-22-085.html
Earliest submission date: May 5, 2022
